Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 224

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The Progression of Chronic Obstructive Pulmonary Disease Is Heterogeneous: The Experience of the BODE Cohort

Casanova, Ciro, de Torres, Juan P., Aguirre-Jaíme, Armando, Pinto-Plata, Victor, Marin, Jose M., Cordoba, Elizabeth, Baz, Rebeca, Cote, Claudia, Celli, Bartolome R. · 2011 · American Journal of Respiratory and Critical Care Medicine

Abstract

RATIONALE: Chronic obstructive pulmonary disease (COPD) is thought to result in rapid and progressive loss of lung function usually expressed as mean values for whole cohorts. OBJECTIVES: Longitudinal studies evaluating individual lung function loss and other domains of COPD progression are needed. METHODS: We evaluated 1,198 stable, well-characterized patients with COPD (1,100 males) recruited in two centers (Florida and Tenerife, Spain) and annually monitored their multidomain progression from 1997 to 2009. Patients were followed for a median of 64 months and up to 10 years. Their individual FEV(1) (L) and BODE index slopes, expressed as annual change, were evaluated using regression models for repeated measures. A total of 751 patients with at least three measurements were used for the analyses. MEASUREMENTS AND MAIN RESULTS: Eighteen percent of patients had a statistically significant FEV(1) slope decline (-86 ml/yr; 95% confidence interval [CI], -32 to -278 ml/yr). Higher baseline FEV(1) (relative risk, 1.857; 95% CI, 1.322-2.610; P < 0.001) and low body mass index (relative risk, 1.071; 95% CI, 1.035-1.106; P < 0.001) were independently associated with FEV(1) decline. The BODE index had a statistically significant increase (0.55, 0.20-1.37 point/yr) in only 14% of patients and these had more severe baseline obstruction. Concordance between FEV1 and BODE change was low (κ Cohen, 16%). Interestingly, 73% of patients had no significant slope change in FEV1 or BODE. Only the BODE change was associated with mortality in patients without FEV(1) progression. CONCLUSIONS: The progression of COPD is very heterogeneous. Most patients show no statistically significant decline of FEV(1) or increase in BODE. The multidimensional evaluation of COPD should offer insight into response to COPD management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201105-0831oc

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 224

Metadata

Authors
Casanova, C., de Torres, J. P., Aguirre-Jaíme, A., Pinto-Plata, V., Marin, J. M., Cordoba, E., Baz, R., Cote, C., & Celli, B. R.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2011-11-01
Volume
184
Issue
9
Pages
1015-1021
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2138808616
Cited by
224
References
6
FWCI
14.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Progression of Chronic Obstructive Pulmonary Disease Is Heterogeneous: The Experience of the BODE Cohort. https://app.cochat.ai/papers/10.1164/rccm.201105-0831oc
The paper
Casanova, C., de Torres, J. P., Aguirre-Jaíme, A., Pinto-Plata, V., Marin, J. M., Cordoba, E., Baz, R., Cote, C., & Celli, B. R. (2011). The Progression of Chronic Obstructive Pulmonary Disease Is Heterogeneous: The Experience of the BODE Cohort. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201105-0831oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.